2761048-50-2
Chemical Structure
C5aR-IN-3
- CAS No.: 2761048-50-2
- Formula:C36H40FN5O3
- Molecular Weight:609.73
IUPAC Name: (2R,3S,4aR,7aR)-1-(2-fluoro-6-methylbenzoyl)-N-(1-methyl-1H-indazol-5-yl)-2-(4-((tetrahydro-2H-pyran-4-yl)amino)phenyl)octahydro-1H-cyclopenta[b]pyridine-3-carboxamide
InChIKey: BAAOLAOSYHGODS-VOZHPAJJSA-N
SMILES: CC1=C(C(F)=CC=C1)C(N2[C@H]([C@H](C[C@H]3CCC[C@H]32)C(NC4=CC5=C(N(N=C5)C)C=C4)=O)C6=CC=C(C=C6)NC7CCOCC7)=O
Biological Activity: C5aR-IN-3 is a potent inhibitor of C5aR. Increased level of C5a has been associated with disorders such as autoimmune disorders and inflammatory disorders. C5aR-IN-3 has the potential for the research of inflammation diseases (extracted from patent WO2022028586A1, compound 89)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
C5aR-IN-3 | C5aR-IN-3 is a potent inhibitor of C5aR. Increased level of C5a has been associated with disorders such as autoimmune disorders and inflammatory disorders. C5aR-IN-3 has the potential for the research of inflammation diseases (extracted from patent WO2022028586A1, compound 89). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
